Furthermore, CKD downregulates hepatic apoA-I gene expression and hepatic LCAT mRNA expression, resulting in decreased HDL and impaired HDL-mediated cholesterol uptake from vascular tissues (30, 31). The gene discussed is LCAT; the disease is chronic kidney disease.